Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C2orf74 antisense RNA 1 (C2orf74-AS1) is a long non-coding RNA (lncRNA) transcribed from the region antisense to the C2orf74 gene on chromosome 2. As an antisense RNA (asRNA), its primary role is likely regulation of gene expression, potentially through mechanisms such as transcriptional interference, regulation of chromatin state, or RNA-RNA interactions. Unlike the C2orf74 protein-coding gene, which is associated with some autoimmune and bowel diseases, there is currently no evidence that C2orf74-AS1 itself functions as a therapeutic target, nor are any interacting drugs, mechanisms of action, or biomarkers known for it. Like other antisense lncRNAs, it may play a context-dependent regulatory role but does not serve as a canonical receptor, enzyme, or drug target. If your focus is on discovering receptors, transporters, or therapeutic protein targets, C2orf74-AS1 does not meet these criteria. It is listed in gene databases under non-coding RNA categories but is not established as a druggable therapeutic target as of current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C2orf74 antisense RNA 1 (C2orf74-AS1).